Exciting news!
Novavax is working on an Omicron XBB specific vaccine with data expected to be presented at this month's FDA VRBPAC meeting.
Unlike Pfizer and Moderna #Novavax hasn’t yet updated its vaccine to specifically target more recently circulating strains of the virus.
1/
Novavax is working on an Omicron XBB specific vaccine with data expected to be presented at this month's FDA VRBPAC meeting.
Unlike Pfizer and Moderna #Novavax hasn’t yet updated its vaccine to specifically target more recently circulating strains of the virus.
1/
“Up through BA.5, our immune responses had held steady,” said Filip Dubovsky, Novavax’s chief medical officer.
“I can tell you right now that this #xbbvariant XBB, XBB.1, it looks different to us.”
2/
#kraken #XBB #XBB15 $NVAX
barrons.com/articles/novav…
“I can tell you right now that this #xbbvariant XBB, XBB.1, it looks different to us.”
2/
#kraken #XBB #XBB15 $NVAX
barrons.com/articles/novav…
Dubovsky said that Novavax has begun making the so-called viral seed needed to begin the manufacturing process for an updated version of its vaccine that would target XBB.1.1.5
#Novavax will present data on the XBB family of viruses at an advisory committee hearing this month
3/
#Novavax will present data on the XBB family of viruses at an advisory committee hearing this month
3/
It's good that #Novavax is developing an #XBB specific vaccine. However, it also sounds a warning.
If Novavax is saying that the immune response to the #XBBvariant looks different, now is not the time for complacency. Please keep testing, masking & meet in well ventilated spaces
If Novavax is saying that the immune response to the #XBBvariant looks different, now is not the time for complacency. Please keep testing, masking & meet in well ventilated spaces
• • •
Missing some Tweet in this thread? You can try to
force a refresh
